Coronary Artery Disease (CAD)

Galectin-3 Could Help Predict Cardiovascular Events in Diabetics

September 09, 2020

A study from ESC Congress 2020 dove deeper into associations between specific biomarkers and risk of CV events in CAD patients with and without diabetes.

Matthew Budoff, MD: Effect of Icosapent Ethyl on Plaque Regression

August 29, 2020

Full data from the EVAPORATE trial presented at ESC Congress 2020 add further evidence of the cardiovascular benefits from use of icosapent ethyl.

Analysis Details Use of Antiplatelet Therapy After Peripheral Vascular Interventions

August 21, 2020

An analysis of data from a Society of Vascular Surgeons registry is shedding light on the use of DAPT in patients following peripheral vascular interventions.

Analysis Details CV Risk Factors and Complications, Outcomes in 70k COVID-19 Patients

August 15, 2020

An analysis of more than 20 studies and 70k patients details the impact cardiovascular risk factors and complications can have on outcomes in patients hospitalized with COVID-19.

Study Details Reproductive Factors and Coronary Artery Disease Risk in Women

August 09, 2020

A new study is detailing the increased risk of coronary artery disease associated with certain reproductive factors in postmenopausal women.

Study Finds Hispanic, Latino Populations Underuse Cardiovascular Medication

August 05, 2020

Among Hispanic and Latino patients with peripheral artery disease 31% reported use of antiplatelet therapy, 26% reported use of lipid-lowering therapy, and 57% reported use of antihypertensive therapy in a new study.

Black Patients at Greater Risk of MACE Following PCI

July 06, 2020

An analysis of 10 randomized clinical trials is shedding new light on the risk of MACE seen by Black patients following PCI versus risk among white counterparts.

Single Question Improves Mortality Estimates in Elderly Atherosclerosis Patients

June 09, 2020

When asked to elderly patients undergoing coronary artery calcium (CAC) scans, the results of a single question offer providers a better understanding of the individual’s risk of death: "On a scale of 1 - 10, how much do you exercise (0-none, 10-always)?"

FDA Expands Use of Ticagrelor to Patients Without History of MI or Stroke

June 02, 2020

The oral antiplatelet drug Ticagrelor (Brilinta, Astra Zeneca), was approved this week by the US Food and Drug Administration (FDA) for use in patients with coronary artery disease (CAD) who are at high risk for a first heart attack or stroke.

Obesity, Diabetes or High Blood Pressure Prematurely Ages Teenage Arteries

May 12, 2020

Obesity, type 2 diabetes or high blood pressure may prematurely age arteries , according to a new study published in the Journal of the American Heart Association.